CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes
New Delhi: The Subject Expert Committee (SEC), which functions under the Central Drugs Standard Control Organisation (CDSCO), has recommended Wockhardt revise the Phase III study of Nafithromycin 400 mg Tablet. This came after the firm presented the proposal for grant of permission to conduct Phase III study vide protocol no. W-4873-302, version 1.0, dated 23.04.2025, […]